Association of FKBP51 with Priming of Autophagy Pathways and Mediation of Antidepressant Treatment Response: Evidence in Cells, Mice, and Humans

PLoS Medicine

Volumn 11, Issue 11, 2014, Pages

  Gassen, Nils C ^a   Hartmann, Jakob ^a   Zschocke, Jürgen ^a   Stepan, Jens ^a   Hafner, Kathrin ^a   Zellner, Andreas ^a   Kirmeier, Thomas ^a   Kollmannsberger, Lorenz ^a   Wagner, Klaus V ^a   Dedic, Nina ^a   Balsevich, Georgia ^a   Deussing, Jan M ^a   Kloiber, Stefan ^a   Lucae, Susanne ^a   Holsboer, Florian ^a   Eder, Matthias ^a   Uhr, Manfred ^a   Ising, Marcus ^a   Schmidt, Mathias V ^a   Rein, Theo ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; AUTOPHAGY PROTEIN 12; BECLIN 1; CHAPERONE; DEXAMETHASONE; FK506 BINDING PROTEIN 51; FLUOXETINE; GLUCOCORTICOID RECEPTOR; GREEN FLUORESCENT PROTEIN; HALOPERIDOL; PAROXETINE; PROTEIN KINASE B; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN; BECN1 PROTEIN, HUMAN; FK 506 BINDING PROTEIN; MEMBRANE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE CULTURE; AUTOPHAGOSOME; AUTOPHAGY; CHRONIC STRESS; CONTROLLED STUDY; DEPRESSION; DSM-IV; FEMALE; FORCED SWIM TEST; GENE INTERACTION; HAMILTON DEPRESSION RATING SCALE; HEK293 CELL LINE; HIPPOCAMPUS; HOSPITAL ADMISSION; HUMAN; HUMAN CELL; IMMOBILITY; IMMUNOPRECIPITATION; LOCOMOTION; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; MOUSE; NERVE CELL; NONHUMAN; OPEN FIELD TEST; PERIPHERAL BLOOD MONONUCLEAR CELL; PERIPHERAL LYMPHOCYTE; PLASMID; POLYMERASE CHAIN REACTION; PREFRONTAL CORTEX; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; RAT; SOCIAL AVOIDANCE BEHAVIOR; STRESS RESPONSE TEST; TREATMENT OUTCOME; TREATMENT RESPONSE; WESTERN BLOTTING; ADULT; ANIMAL; BLOOD CELL; C57BL MOUSE; DEPRESSIVE DISORDER; DRUG EFFECTS; GENETICS; KNOCKOUT MOUSE; MENTAL STRESS; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; SPRAGUE DAWLEY RAT; YOUNG ADULT;

ADULT; AMITRIPTYLINE; ANIMALS; ANTIDEPRESSIVE AGENTS; APOPTOSIS REGULATORY PROTEINS; AUTOPHAGY; BLOOD CELLS; DEPRESSION; DEPRESSIVE DISORDER; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MEMBRANE PROTEINS; MICE, INBRED C57BL; MICE, KNOCKOUT; MIDDLE AGED; PAROXETINE; RATS, SPRAGUE-DAWLEY; STRESS, PSYCHOLOGICAL; TACROLIMUS BINDING PROTEINS; YOUNG ADULT;

EID: 84922339636     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1001755     Document Type: Article

References (71)

1. Kessler RC, Aguilar-Gaxiola S, Alonso J, Chatterji S, Lee S, et al. (2009) The WHO World Mental Health (WMH) Surveys. Psychiatrie (Stuttg) 6: 5–9.
2. Geddes JR, Miklowitz DJ, (2013) Treatment of bipolar disorder. Lancet 381: 1672–1682.
3. Klengel T, Mehta D, Anacker C, Rex-Haffner M, Pruessner JC, et al. (2013) Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions. Nat Neurosci 16: 33–41.
4. Attwood BK, Bourgognon JM, Patel S, Mucha M, Schiavon E, et al. (2011) Neuropsin cleaves EphB2 in the amygdala to control anxiety. Nature 473: 372–375.
5. Hartmann J, Wagner KV, Liebl C, Scharf SH, Wang XD, et al. (2012) The involvement of FK506-binding protein 51 (FKBP5) in the behavioral and neuroendocrine effects of chronic social defeat stress. Neuropharmacology 62: 332–339.
6. Touma C, Gassen NC, Herrmann L, Cheung-Flynn J, Bull DR, et al. (2011) FK506 binding protein 5 shapes stress responsiveness: modulation of neuroendocrine reactivity and coping behavior. Biol Psychiatry 70: 928–936.
7. Wochnik GM, Rüegg J, Abel GA, Schmidt U, Holsboer F, et al. (2005) FK506-binding proteins 51 and 52 differentially regulate dynein interaction and nuclear translocation of the glucocorticoid receptor in mammalian cells. J Biol Chem 280: 4609–4616.
8. Binder EB, Salyakina D, Lichtner P, Wochnik GM, Ising M, et al. (2004) Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat Genet 36: 1319–1325.
9. Lekman M, Laje G, Charney D, Rush AJ, Wilson AF, et al. (2008) The FKBP5-gene in depression and treatment response—an association study in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Cohort. Biol Psychiatry 63: 1103–1110.
10. Zou YF, Wang F, Feng XL, Li WF, Tao JH, et al. (2010) Meta-analysis of FKBP5 gene polymorphisms association with treatment response in patients with mood disorders. Neurosci Lett 484: 56–61.
11. Laje G, Perlis RH, Rush AJ, McMahon FJ, (2009) Pharmacogenetics studies in STAR*D: strengths, limitations, and results. Psychiatr Serv 60: 1446–1457.
12. De Kloet ER, Joels M, Holsboer F, (2005) Stress and the brain: from adaptation to disease. Nat Rev Neurosci 6: 463–475.
13. Holsboer F, (2000) The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 23: 477–501.
14. Zschocke J, Zimmermann N, Berning B, Ganal V, Holsboer F, et al. (2011) Antidepressant drugs diversely affect autophagy pathways in astrocytes and neurons—dissociation from cholesterol homeostasis. Neuropsychopharmacology 36: 1754–1768.
15. Rossi M, Munarriz ER, Bartesaghi S, Milanese M, Dinsdale D, et al. (2009) Desmethylclomipramine induces the accumulation of autophagy markers by blocking autophagic flux. J Cell Sci 122: 3330–3339.
16. Taipale M, Jarosz DF, Lindquist S, (2010) HSP90 at the hub of protein homeostasis: emerging mechanistic insights. Nat Rev Mol Cell Biol 11: 515–528.
17. Mizushima N, Komatsu M, (2011) Autophagy: renovation of cells and tissues. Cell 147: 728–741.
18. Nakatogawa H, Suzuki K, Kamada Y, Ohsumi Y, (2009) Dynamics and diversity in autophagy mechanisms: lessons from yeast. Nat Rev Mol Cell Biol 10: 458–467.
19. Wang RC, Wei Y, An Z, Zou Z, Xiao G, et al. (2012) Akt-mediated regulation of autophagy and tumorigenesis through Beclin 1 phosphorylation. Science 338: 956–959.
20. Harris H, Rubinsztein DC, (2012) Control of autophagy as a therapy for neurodegenerative disease. Nat Rev Neurol 8: 108–117.
21. Levine B, Kroemer G, (2008) Autophagy in the pathogenesis of disease. Cell 132: 27–42.
22. Welberg L, (2012) Neurotransmission: autophagy regulates transmission. Nat Rev Neurosci 13: 362–363.
23. Cai Q, Lu L, Tian JH, Zhu YB, Qiao H, et al. (2010) Snapin-regulated late endosomal transport is critical for efficient autophagy-lysosomal function in neurons. Neuron 68: 73–86.
24. Ma J, Hou LN, Rong ZX, Liang P, Fang C, et al. (2013) Antidepressant desipramine leads to C6 glioma cell autophagy: implication for the adjuvant therapy of cancer. Anticancer Agents Med Chem 13: 254–260.
25. Chen J, Korostyshevsky D, Lee S, Perlstein EO, (2012) Accumulation of an antidepressant in vesiculogenic membranes of yeast cells triggers autophagy. PLoS ONE 7: e34024.
26. Kara NZ, Toker L, Agam G, Anderson GW, Belmaker RH, et al. (2013) Trehalose induced antidepressant-like effects and autophagy enhancement in mice. Psychopharmacology (Berl) 229: 367–375.
27. Cleary C, Linde JA, Hiscock KM, Hadas I, Belmaker RH, et al. (2008) Antidepressive-like effects of rapamycin in animal models: implications for mTOR inhibition as a new target for treatment of affective disorders. Brain Res Bull 76: 469–473.
28. Nestler EJ, Hyman SE, (2010) Animal models of neuropsychiatric disorders. Nat Neurosci 13: 1161–1169.
29. Deussing JM, (2006) Animal models of depression. Drug Discov Today 3: 375–383.
30. Wang XD, Chen Y, Wolf M, Wagner KV, Liebl C, et al. (2011) Forebrain CRHR1 deficiency attenuates chronic stress-induced cognitive deficits and dendritic remodeling. Neurobiol Dis 42: 300–310.
31. Berton O, McClung CA, Dileone RJ, Krishnan V, Renthal W, et al. (2006) Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 311: 864–868.
32. Skeen JE, Bhaskar PT, Chen CC, Chen WS, Peng XD, et al. (2006) Akt deficiency impairs normal cell proliferation and suppresses oncogenesis in a p53-independent and mTORC1-dependent manner. Cancer Cell 10: 269–280.
33. Perisic T, Zimmermann N, Kirmeier T, Asmus M, Tuorto F, et al. (2010) Valproate and amitriptyline exert common and divergent influences on global and gene promoter-specific chromatin modifications in rat primary astrocytes. Neuropsychopharmacology 35: 792–805.
34. Franke B, Figiel M, Engele J, (1998) CNS glia are targets for GDNF and neurturin. Histochem Cell Biol 110: 595–601.
35. Schumann BG, Jutzi P, Roditi I, (2011) Genome-wide RNAi screens in bloodstream form trypanosomes identify drug transporters. Mol Biochem Parasitol 175: 91–94.
36. Kim D, Sun M, He L, Zhou QH, Chen J, et al. (2010) A small molecule inhibits Akt through direct binding to Akt and preventing Akt membrane translocation. J Biol Chem 285: 8383–8394.
37. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, et al. (1999) Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96: 857–868.
38. Kabeya Y, Mizushima N, Ueno T, Yamamoto A, Kirisako T, et al. (2000) LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J 19: 5720–5728.
39. Wagner KV, Marinescu D, Hartmann J, Wang XD, Labermaier C, et al. (2012) Differences in FKBP51 regulation following chronic social defeat stress correlate with individual stress sensitivity: influence of paroxetine treatment. Neuropsychopharmacology 37: 2797–2808.
40. Wagner KV, Wang XD, Liebl C, Scharf SH, Müller MB, et al. (2011) Pituitary glucocorticoid receptor deletion reduces vulnerability to chronic stress. Psychoneuroendocrinology 36: 579–587.
41. McIlwain KL, Merriweather MY, Yuva-Paylor LA, Paylor R, (2001) The use of behavioral test batteries: effects of training history. Physiol Behav 73: 705–717.
42. Golden SA, Covington HE, 3rdBerton O, Russo SJ, (2011) A standardized protocol for repeated social defeat stress in mice. Nat Protoc 6: 1183–1191.
43. Fluttert M, Dalm S, Oitzl MS, (2000) A refined method for sequential blood sampling by tail incision in rats. Lab Anim 34: 372–378.
44. Uhr M, Steckler T, Yassouridis A, Holsboer F, (2000) Penetration of amitriptyline, but not of fluoxetine, into brain is enhanced in mice with blood-brain barrier deficiency due to mdr1a P-glycoprotein gene disruption. Neuropsychopharmacology 22: 380–387.
45. Uhr M, Grauer MT, Holsboer F, (2003) Differential enhancement of antidepressant penetration into the brain in mice with abcb1ab (mdr1ab) P-glycoprotein gene disruption. Biol Psychiatry 54: 840–846.
46. Hennings JM, Owashi T, Binder EB, Horstmann S, Menke A, et al. (2009) Clinical characteristics and treatment outcome in a representative sample of depressed inpatients—findings from the Munich Antidepressant Response Signature (MARS) project. J Psychiatr Res 43: 215–229.
47. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edition. Washington (District of Columbia): American Psychiatric Association.
48. Overall JE, Rhoades HM, (1982) Use of the Hamilton Rating Scale for classification of depressive disorders. Compr Psychiatry 23: 370–376.
49. Hiemke C, Baumann P, Bergemann N, Conca A, Dietmaier O, et al. (2011) AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011. Pharmacopsychiatry 44: 195–235.
50. Taksande BG, Kotagale NR, Tripathi SJ, Ugale RR, Chopde CT, (2009) Antidepressant like effect of selective serotonin reuptake inhibitors involve modulation of imidazoline receptors by agmatine. Neuropharmacology 57: 415–424.
51. Thoeringer CK, Erhardt A, Sillaber I, Mueller MB, Ohl F, et al. (2010) Long-term anxiolytic and antidepressant-like behavioural effects of tiagabine, a selective GABA transporter-1 (GAT-1) inhibitor, coincide with a decrease in HPA system activity in C57BL/6 mice. J Psychopharmacol 24: 733–743.
52. Galeotti N, Ghelardini C, (2012) Selective modulation of the PKCvarepsilon/p38MAP kinase signalling pathway for the antidepressant-like activity of amitriptyline. Neuropharmacology 62: 289–296.
53. Pei H, Li L, Fridley BL, Jenkins GD, Kalari KR, et al. (2009) FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt. Cancer Cell 16: 259–266.
54. Klionsky DJ, Abdalla FC, Abeliovich H, Abraham RT, Acevedo-Arozena A, et al. (2012) Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 8: 445–544.
55. Jeon SH, Kim SH, Kim Y, Kim YS, Lim Y, et al. (2011) The tricyclic antidepressant imipramine induces autophagic cell death in U-87MG glioma cells. Biochem Biophys Res Commun 413: 311–317.
56. Huang W, Zhao Y, Zhu X, Cai Z, Wang S, et al. (2013) Fluoxetine upregulates phosphorylated-AKT and phosphorylated-ERK1/2 proteins in neural stem cells: evidence for a crosstalk between AKT and ERK1/2 pathways. J Mol Neurosci 49: 244–249.
57. Li N, Lee B, Liu RJ, Banasr M, Dwyer JM, et al. (2010) mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 329: 959–964.
58. Voleti B, Navarria A, Liu RJ, Banasr M, Li N, et al. (2013) Scopolamine rapidly increases mammalian target of rapamycin complex 1 signaling, synaptogenesis, and antidepressant behavioral responses. Biol Psychiatry 74: 742–749.
59. Hubler TR, Scammell JG, (2004) Intronic hormone response elements mediate regulation of FKBP5 by progestins and glucocorticoids. Cell Stress Chaperones 9: 243–252.
60. Laane E, Tamm KP, Buentke E, Ito K, Kharaziha P, et al. (2009) Cell death induced by dexamethasone in lymphoid leukemia is mediated through initiation of autophagy. Cell Death Differ 16: 1018–1029.
61. Scammell JG, Denny WB, Valentine DL, Smith DF, (2001) Overexpression of the FK506-binding immunophilin FKBP51 is the common cause of glucocorticoid resistance in three New World primates. Gen Comp Endocrinol 124: 152–165.
62. Bhuiyan MS, Tagashira H, Fukunaga K, (2011) Sigma-1 receptor stimulation with fluvoxamine activates Akt-eNOS signaling in the thoracic aorta of ovariectomized rats with abdominal aortic banding. Eur J Pharmacol 650: 621–628.
63. Basta-Kaim A, Budziszewska B, Jaworska-Feil L, Tetich M, Kubera M, et al. (2005) Inhibitory effect of imipramine on the human corticotropin-releasing-hormone gene promoter activity operates through a PI3-K/AKT mediated pathway. Neuropharmacology 49: 156–164.
64. Manning BD, Cantley LC, (2007) AKT/PKB signaling: navigating downstream. Cell 129: 1261–1274.
65. Berton O, Nestler EJ, (2006) New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci 7: 137–151.
66. Hernandez D, Torres CA, Setlik W, Cebrian C, Mosharov EV, et al. (2012) Regulation of presynaptic neurotransmission by macroautophagy. Neuron 74: 277–284.
67. Kim CS, Chang PY, Johnston D, (2012) Enhancement of dorsal hippocampal activity by knockdown of HCN1 channels leads to anxiolytic- and antidepressant-like behaviors. Neuron 75: 503–516.
68. O'Leary JC, 3rdDharia S, Blair LJ, Brady S, Johnson AG, et al. (2011) A new anti-depressive strategy for the elderly: ablation of FKBP5/FKBP51. PLoS ONE 6: e24840.
69. Jinwal UK, Koren J, 3rdBorysov SI, Schmid AB, Abisambra JF, et al. (2010) The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules. J Neurosci 30: 591–599.
70. Barabasi AL, Gulbahce N, Loscalzo J, (2011) Network medicine: a network-based approach to human disease. Nat Rev Genet 12: 56–68.
71. Luo L, Callaway EM, Svoboda K, (2008) Genetic dissection of neural circuits. Neuron 57: 634–660.